M42 Managing Director and Group Chief Executive Officer, Hasan Jasem Al Nowais, pledged to take Abu Dhabi’s new innovations to the global stage after a historic live demonstration of a remote telerobotic procedure. Controlled and live-streamed from Abu Dhabi, the procedure was performed on a
M42
Imperial College London Diabetes Centre (ICLDC), part of the M42 group, has become the first centre in Abu Dhabi to partner with bookdialysis, the leading online booking engine for holiday dialysis patients. ICLDC now joins a coveted network of top-tier clinics in more than 50 countries listed on the free booking platform, offering global travelers […]
M42, an Abu Dhabi-based, global tech-enabled health powerhouse, has unveiled AIRIS-TB, an AI-powered chest X-ray for tuberculosis (TB) screening centers. The technology, which was revealed at Abu Dhabi Global Healthcare Week, uses advanced AI to detect abnormalities in chest X-rays and instantly flags abnormal results for further review by a radiologist. Developed by M42
M42, a global tech-enabled health powerhouse, has launched the next generation of its open-access generative AI Clinical Large Language Model (LLM), Med42, during Abu Dhabi Global Healthcare Week. Building upon the success of the initial launch, Med42 represents the next evolution in AI-driven health innovation, poised to advance healthcare AI and transform patient care,
The Department of Health – Abu Dhabi (DoH),the regulator of the healthcare sector in the emirate, and M42, a global tech-enabled health powerhouse, have collaborated to launch a groundbreaking initiative and strategic priority, the Abu Dhabi Biobank, with its first offering being the region’s largest hybrid cord blood bank. Reinforcing the Emirate’s position as a
M42, a first-of-its-kind tech-enabled global health powerhouse, has unveiled a new Advisory Board, to impactfully disrupt and transform the global health sector through personalized, preventive and precision tech. Comprising some of the world’s leading health and technology experts in the areas of personal remote care, pharmaceuticals, tech and longevity, the Advisory
M42, a global tech-enabled health powerhouse, has achieved the prestigious Global Healthcare Accreditation (GHA) Certification for Excellence in Medical Travel Patient Experience from the United States for its pioneering approach. With an outstanding overall score of 91 percent, this certification reaffirms M42’s commitment to delivering exceptional care and support
Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully completed a complex heart transplant for Muhammad Al Ketbi suffering from familial cardiomyopathy. The 28-year-old Emirati patient, who had been suffering with heart disease for more than a decade, developed multi-organ failure, and was initially placed on an Extracorporeal membrane oxygenation
A renowned surgeon at Danat Al Emarat Hospital for Women & Children, part of the M42 group, has performed life-changing endometriosis treatment on an international patient using ultrasonic scalpel technology. Twenty-four-year-old Chloe Bremner, from the UK, sought out his expert care after realizing what the world-class facility, coupled with unmatched patient-centered
M42, a leading global health-tech powerhouse, is proud to unveil its lineup of top global health experts to convene on the M42 Main Stage at the inaugural Abu Dhabi Global Healthcare Week 2024 (ADGHW). ADGHW, hosted by the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, under […]
M42, a first-of-its-kind tech-enabled global health powerhouse, has signed a groundbreaking agreement with AstraZeneca, a global leader in science-led biopharmaceuticals, to advance preventive healthcare and next-generation precision medicine. As AstraZeneca’s clinical genomics partner of choice in the Middle East region, M42 will conduct sequencing of hereditary breast
Mubadala Health Dubai, part of the M42 group, has been successfully accredited by the Joint Commission International (JCI) and now proudly displays the coveted Gold Seal of Approval. This significant achievement marks a milestone for Mubadala Health Dubai as it attains its inaugural JCI accreditation in an impressive timeframe of less than 18 months since […]
In a regional first, the Imperial College London Diabetes Centre (ICLDC), part of the M42 group, announced it will open a dedicated one-stop facility in Madinat Zayed to provide comprehensive care for diabetes and endocrine patients. With a proven track-record of nearly two decades, ICLDC’s model for diabetes prevention and management has significantly reduced HbA1c […]
In celebration of International Women’s Day on March 8, health-tech powerhouse M42 is launching the ‘Laha Wellness Hub,’ a dedicated preventive women’s wellness clinic at HealthPlus Family Clinic in Al Bandar, Abu Dhabi. This specialized clinic, tailored for women aged 35 and above, aims to empower women through a holistic approach to wellness, focusing on […]
Amana Healthcare, an M42 company, recently hosted their Long-Term Care Convention on January 20. The all-day event in Abu Dhabi opened with a welcome address by Dr. Jason Gray, Chief Executive Officer of Amana Healthcare. The convention provided a platform for insightful discussions on important healthcare topics, including the challenges in long-term care and post-COVID
M42, the global tech-enabled health powerhouse based in Abu Dhabi, is set to revolutionize gut health with the launch of the M42 Microbiome Wellness Program. This groundbreaking initiative, available exclusively at M42, combines advanced DNA sequencing technology with personalized consultations to set new standards for well-being. The program is available at Mubadala
M42, a global tech-enabled health powerhouse, has partnered with one of the world’s leading children’s hospitals, Great Ormond Street Hospital for Children (GOSH), in London, part of the National Health Service (NHS) in the United Kingdom. Together, the partners will introduce an innovative education initiative to enhance pediatric critical and complex care in
M42, a global tech-enabled health powerhouse, has partnered with the US-based biotechnology company SomaLogic to launch a proteomics grant competition, a first in the region, aimed at inspiring researchers to harness the vast potential of proteomics research. Proteomics, the study of proteomes, the complete set of proteins produced in an organism, plays a pivotal role […]
M42 — a first-of-its-kind health powerhouse committed to reshaping the sustainable future of health with technology as a key enabler — and Broad Institute of MIT and Harvard will work with Microsoft and the International Center for Genetic Disease. The group will leverage the Terra platform to explore scenarios for precision health discovery and delivery, […]
M42, a global tech-enabled health powerhouse, in collaboration with the Environment Agency – Abu Dhabi (EAD), has completed the sequencing and analysis of the Ghaf tree, the national tree of the UAE, to further build upon previous research led by Khalifa Center for Genetic Engineering and Biotechnology. The tree is renowned for its ability to […]